Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dianthus Therapeutics, Inc.(DNTH) | 2,104,184 | 1,899,593 | -204,591 | $205.12M | $167.26M | 39.08% | -$37.86M |
| CG Oncology, Inc.(CGON) | 1,398,948 | 1,348,948 | -50,000 | $99.40M | $95.63M | 22.35% | -$3.77M |
| Oruka Therapeutics, Inc.(ORKA) | 760,424 | 785,424 | +25,000 | $72.37M | $65.42M | 15.29% | -$6.95M |
| Jade Biosciences Inc | 1,700,708 | 2,000,000 | +299,292 | $37.79M | $28.10M | 6.57% | -$9.69M |
| Enliven Therapeutics Inc | 550,000 | 550,000 | 0 | $27.91M | $25.21M | 5.89% | -$2.70M |
| Perspective Therapeutics, Inc.(CATX) | 6,299,999 | 6,067,999 | -232,000 | $21.48M | $16.69M | 3.90% | -$4.80M |
| Aktis Oncology, Inc.(AKTS) | 484,200 | 484,200 | 0 | $15.61M | $9.43M | 2.20% | -$6.18M |
| Immunic, Inc.(IMUX) | 669,941 | 669,941 | 0 | $10.30M | $6.23M | 1.46% | -$4.07M |
| Mobia Med Inc | 798,282 | 324,676 | -473,606 | $10.70M | $3.07M | 0.72% | -$7.63M |
| Palvella Therapeutics, Inc.(PVLA) | 70,000 | 20,000 | -50,000 | $10.70M | $2.76M | 0.64% | -$7.94M |
| Nuvectis Pharma, Inc.(NVCT) | 200,000 | 100,415 | -99,585 | $3.68M | $2.12M | 0.50% | -$1.56M |
| Satellos Bioscience Inc.(MSLE) | 387,769 | 164,019 | -223,750 | $3.01M | $1.39M | 0.33% | -$1.62M |
| Context Therapeutics Inc.(CNTX) | 4,998,267 | 4,060,254 | -938,013 | $2.77M | $1.22M | 0.29% | -$1.55M |
| Karyopharm Therapeutics Inc.(KPTI) | 924,487 | 884,900 | -39,587 | $9.03M | $1.08M | 0.25% | -$7.95M |
| Senseonics Holdings, Inc.(SENS) | 1,600,000 | 100,000 | -1,500,000 | $9.09M | $1.02M | 0.24% | -$8.07M |
| Scynexis Inc | 260,206 | 153,613 | -106,593 | $1.06M | $758.8K | 0.18% | -$300.2K |
| Avalyn Pharmaceuticals Inc | 60,000 | 20,000 | -40,000 | $1.98M | $569.8K | 0.13% | -$1.41M |
| Abbott Laboratories | 10,000 | 0 | -10,000 | $907.4K | $0 | — | -$907.4K |
| Alamar Biosciences Inc | 110,000 | 0 | -110,000 | $2.98M | $0 | — | -$2.98M |
| Boston Scientific Corporation(BSX) | 80,000 | 0 | -80,000 | $3.41M | $0 | — | -$3.41M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 43,853 | 0 | -43,853 | $334.2K | $0 | — | -$334.2K |
| BridgeBio Pharma, Inc.(BBIO) | 10,000 | 0 | -10,000 | $744.8K | $0 | — | -$744.8K |
| Charles River Laboratories International, Inc.(CRL) | 10,000 | 0 | -10,000 | $2.27M | $0 | — | -$2.27M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 80,000 | 0 | -80,000 | $1.20M | $0 | — | -$1.20M |
| DexCom, Inc.(DXCM) | 100,000 | 0 | -100,000 | $6.74M | $0 | — | -$6.74M |
| Encompass Health Corporation(EHC) | 42,000 | 0 | -42,000 | $4.25M | $0 | — | -$4.25M |
| Evommune, Inc.(EVMN) | 75,000 | 0 | -75,000 | $996.8K | $0 | — | -$996.8K |
| Genmab A/SADS(GMAB) | 50,000 | 0 | -50,000 | $1.37M | $0 | — | -$1.37M |
| Gilead Sciences, Inc.(GILD) | 20,000 | 0 | -20,000 | $2.53M | $0 | — | -$2.53M |
| Insulet Corporation(PODD) | 24,000 | 0 | -24,000 | $3.65M | $0 | — | -$3.65M |
| Intellia Therapeutics, Inc.(NTLA) | 75,000 | 0 | -75,000 | $1.27M | $0 | — | -$1.27M |
| Kailera Therapeutics Inc | 80,000 | 0 | -80,000 | $1.76M | $0 | — | -$1.76M |
| Legend Biotech CorporationADS(LEGN) | 15,000 | 0 | -15,000 | $433.2K | $0 | — | -$433.2K |
| Medtronic plcSHS(MDT) | 70,000 | 0 | -70,000 | $5.48M | $0 | — | -$5.48M |
| Oddity Tech LtdCL A SHS CL A | 70,000 | 0 | -70,000 | $1.06M | $0 | — | -$1.06M |
| Peloton Interactive, Inc.CL A(PTON) | 100,000 | 0 | -100,000 | $591.0K | $0 | — | -$591.0K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 200,000 | 0 | -200,000 | $2.17M | $0 | — | -$2.17M |
| Repligen Corporation(RGEN) | 77,800 | 0 | -77,800 | $10.62M | $0 | — | -$10.62M |
| Savara Inc.(SVRA) | 50,000 | 0 | -50,000 | $308.0K | $0 | — | -$308.0K |
| Structure Therapeutics IncADS | 98,000 | 0 | -98,000 | $5.26M | $0 | — | -$5.26M |
| Tempus AI, Inc.CL A(TEM) | 105,000 | 0 | -105,000 | $6.08M | $0 | — | -$6.08M |
| Tenax Therapeutics, Inc.(TENX) | 265,934 | 0 | -265,934 | $3.87M | $0 | — | -$3.87M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 200,000 | 0 | -200,000 | $6.78M | $0 | — | -$6.78M |
| Trevi Therapeutics, Inc.(TRVI) | 6,660 | 0 | -6,660 | $124.2K | $0 | — | -$124.2K |
| Vir Biotechnology, Inc.(VIR) | 519,300 | 0 | -519,300 | $5.29M | $0 | — | -$5.29M |